You searched for "stent"

1625 results found

Professor Heinz Stammberger’s pioneering contribution and legacy in the field of FESS

It is no exaggeration to say that functional endoscopic sinus surgery would not exist in its current form without Heinz Stammberger. Prof Valerie Lund traces the development of this relatively recent surgical technique. In the early 1980s, a happy combination...

Early detection pathways for congenital cytomegalovirus for infants referred from the newborn hearing screen

This article discusses requirements for an early congenital cytomegalovirus (cCMV) detection pathway to ensure children do not miss out on the opportunity for timely diagnosis and treatment. The pathways described are currently in use in England and apply to well...

Head and neck cancer and PET-CT

Positron emission tomography-computed tomography (PET-CT) is an imaging technique in which abnormalities of tissue metabolism are precisely superimposed onto the anatomy. It relies on the premise that malignant cells are more metabolically active compared with non-malignant cells. On this basis,...

Sugammadex

Scott Russell is an anaesthetist with an almost unrivalled experience of complex head and neck surgery, and has seen all manner of new ideas come and go. However, in this article he describes a new pharmaceutical agent that is already...

Getting started in research

Dave had a passion for research and was very encouraging in developing a research interest in others. Bhavisha and Amanda are currently working with a team of researchers, patients, research funders, the Department of Health and Social Care and NHS England, to develop the 2023-2028 UK Action Plan for Hearing loss and Tinnitus Research - a set of recommendations to grow hearing research in the UK. Here, they discuss their journey to hearing care research and how you could get involved in the world of research.

Comparing AutoREM accuracy to NAL-NL2 targets: real patient data and simulator verification

A new study examines how accurately AutoREMs from four major brands hit NAL-NL2 targets, revealing strengths, limits and clinical implications. Automatic real ear measurements (AutoREMs) have emerged as a promising way to make hearing aid fittings faster and more consistent....

In conversation with Dr Abitbol- a Q&A by Vasasnt Oswal

Interview by Vasant Oswal of Dr Abitbol, Ancien Chef de Clinique at the University of Paris, France. Vasant Oswal Dr Abitbol Dr Abitbol developed innovative diagnostic and therapeutic techniques, which include vocal dynamic exploration to look at the vocal folds...

OAEE UPDATE - Urgent Call for Surgical Supplies in Ukraine

UK professionals have called for aid in sending surgical equipment to Ukraine during Russian invasion.

CEORL-HNS 2024

Held from June 15 to 19 at the Dublin Convention Centre, this was an unmissable event for ENT surgeons and allied health professionals across the world. Hosted by Professor John Russell, the President of the Confederation, the event brought together...

Wireless bone conduction headphones – Aftershokz Wireless Trekz Titanium

Trekz Titanium wireless headphones claim to be the safest alternative to traditional sport headphones, delivering music through the cheekbones and leaving the ears free to hear all surrounding sounds. Designed with athletes in mind, Gareth Smith donned his running gear...

The Laryngeal Pacemaker – developing an innovative solution for bilateral vocal fold paralysis

Bilateral vocal fold paralysis is a difficult condition to manage, with surgical interventions previously limited to tracheostomy or arytenoidectomy. Re-innervation surgery has been developed and, in recent years, a Laryngeal Pacemaker is now in clinical trials. We speak to two...

The Laryngeal Pacemaker – developing an innovative solution for bilateral vocal fold paralysis

Bilateral vocal fold paralysis is a difficult condition to manage, with surgical interventions previously limited to tracheostomy or arytenoidectomy. Re-innervation surgery has been developed and, in recent years, a Laryngeal Pacemaker is now in clinical trials. We speak to two...